QOF database

Home | News | Downloads
LOCHMABEN MEDICAL GROUP

LOCHMABEN MEDICAL GROUP

Lochmaben Medical Group, 42-44 High Street, Lochmaben, DG11 1NH

HF 4

The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.

IndicatorYearNumeratorDenominatorRatioCentile
HF 4 2010 16 16 100.0%
HF 4 2011 17 20 85.0%
HF 4 2012 14 15 93.3%
HF 4 2013 16 17 94.1%
HF004(S) 2014 None None NA%
HF004(S) 2015 None None NA%
HF004(S) 2016 None None NA%